| Efficacy of Adaptogens in Patients With Long COVID-19 (NCT04795557) | Swedish Herbal Institute AB | 2021-04-19 |
| Investigating Temporalis and Masseter Botox Injection Before Orthognathic Surgery to Improve Postoperative Pain (NCT04794504) | Kingsway Oral & Maxillofacial Surgery | 2021-04-19 |
| Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders (NCT04079179) | Carl Allen | 2021-04-19 |
| Efficacy and Safety of Three Doses of Florence Oral Suspension in Adults With Eosinophilic Esophagitis (NCT02873468) | EMS | 2021-04-19 |
| Study Assessing the Efficacy, Safety and PK of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (NCT04589650) | Novartis Pharmaceuticals | 2021-04-19 |
| Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors (NCT04716634) | BeiGene | 2021-04-19 |
| Phase 2a Study of HU6 in Subjects With Elevated Liver Fat and High BMI Volunteers (NCT04874233) | Rivus Pharmaceuticals, Inc. | 2021-04-19 |
| TAC T-cells for the Treatment of HER2-positive Solid Tumors (NCT04727151) | Triumvira Immunologics, Inc. | 2021-04-19 |
| A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care (NCT04834544) | Peking University Third Hospital | 2021-04-19 |
| A Clinical Study of SHR8554 Injection for the Treatment of Pain After Orthopedic Surgery (NCT04794738) | Jiangsu HengRui Medicine Co., Ltd. | 2021-04-18 |
| Effects of Treatment With N- Acetylcysteine on Visual Outcomes in Patients With Retinitis Pigmentosa (NCT04864496) | Shahid Beheshti University of Medical Sciences | 2021-04-17 |
| Efficacy of Nitrous Oxide in OCD: Pilot Study (NCT03826693) | Stanford University | 2021-04-17 |
| Menstrual Blood Stem Cells in Severe Covid-19 (NCT05019287) | Avicenna Research Institute | 2021-04-17 |
| FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases (NCT04832776) | Fudan University | 2021-04-17 |
| A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML (NCT04730258) | Treadwell Therapeutics, Inc | 2021-04-16 |
| Camrelizumab Plus Chemoradiotherapy for Patients With Locoregional Cancer of Nasal Cavity and Paranasal Sinuses (NCT05114707) | Sun Yat-sen University | 2021-04-16 |
| Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias (NCT04754399) | University of Michigan Rogel Cancer Center | 2021-04-16 |
| Teriflunomide vs. Placebo During Gluten Challenge in Celiac Disease (NCT04806737) | Oslo University Hospital | 2021-04-16 |
| Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) (NCT04625647) | SWOG Cancer Research Network | 2021-04-16 |
| Pre-operative Tamsulosin and Time to Spontaneous Void After Hysterectomy (NCT04859660) | University of Arizona | 2021-04-16 |
| HM-178: Assessing Methods for Improvement in Methotrexate Toxicity Management and Detection of Central Nervous System Involvement of Aggressive Lymphoma (NCT04668768) | Fox Chase Cancer Center | 2021-04-16 |
| Furosemide as Supportive Therapy for COVID-19 Respiratory Failure (NCT04588792) | Dr. John Muscedere | 2021-04-16 |
| Sargramostim (GM-CSF) + PD-1 (NCT04703426) | Dana-Farber Cancer Institute | 2021-04-16 |
| Dexamethasone for Cerebral Toxoplasmosis (NCT04341155) | Universitas Padjadjaran | 2021-04-16 |
| PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER (NCT07178808) | Banner Health | 2021-04-16 |
| Rosacea and Ivermectin (NCT04275999) | Wake Forest University Health Sciences | 2021-04-16 |
| A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study (NCT04641247) | GlaxoSmithKline | 2021-04-16 |
| Tolebrutinib, a Brain-penetrant Bruton's Tyrosine Kinase Inhibitor, for the Modulation of Chronically Inflamed White Matter Lesions in Multiple Sclerosis (NCT04742400) | National Institute of Neurological Disorders and Stroke (NINDS) | 2021-04-15 |
| Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD (NCT04580420) | Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 2021-04-15 |
| Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC (NCT04912765) | National Cancer Centre, Singapore | 2021-04-15 |
| Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy (NCT04812002) | Women's Hospital School Of Medicine Zhejiang University | 2021-04-15 |
| Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung Cancer (NCT04726215) | CellSight Technologies, Inc. | 2021-04-15 |
| Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib (NCT04614194) | University of Texas Southwestern Medical Center | 2021-04-15 |
| Medication Development for Protracted Abstinence in Alcoholism: CORT118335 Versus Placebo (NCT04466215) | The Scripps Research Institute | 2021-04-15 |
| A Pilot Study on the Effect of Cannabis Oil in Untreatable Liver Cancer Patients (NCT06518434) | University Medical Center Groningen | 2021-04-15 |
| Safety and Efficacy of Pro-ocular™ 1% in Daily Scleral Lens Wearing Patients With Ocular Graft-versus-Host Disease (NCT04769648) | Glia, LLC | 2021-04-15 |
| Study to Evaluate Tezepelumab in Adults With Chronic Spontaneous Urticaria (NCT04833855) | Amgen | 2021-04-15 |
| Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer (NCT03709550) | Roswell Park Cancer Institute | 2021-04-15 |
| Nebivolol 0.5, 1.0, or Timolol 0.5 Suspension Compared to Timolol 0.5 Solution to Treat Glaucoma/Ocular Hypertension (NCT04910100) | Betaliq, Inc. | 2021-04-15 |
| Imaging Immune Activation in COVID-19 (NCT04815096) | CellSight Technologies, Inc. | 2021-04-15 |
| Senicapoc and Dehydrated Stomatocytosis (NCT04372498) | Boston Children's Hospital | 2021-04-15 |
| Clinical Study of HMPL-689 for Relapsed/Refractory Marginal Zone Lymphoma and Follicular Lymphoma (NCT04849351) | Hutchison Medipharma Limited | 2021-04-15 |
| Sintilimab (IBI308) in Combination With Chidamide and Azacitidine in Refractory or Relapsed PTCL (NCT04052659) | Peking University | 2021-04-15 |
| Human Challenge With Live-attenuated Rotavirus to Assess Next-generation Rotavirus Vaccines in Africa (NCT04658914) | Centre for Infectious Disease Research in Zambia | 2021-04-15 |
| Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia (NCT04159103) | ModernaTX, Inc. | 2021-04-15 |
| A Study of BMS-936558 With SBRT After Induction Chemotherapy in Cholangiocarcinoma (NCT04648319) | American University of Beirut Medical Center | 2021-04-15 |
| A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy (NCT04151563) | Bristol-Myers Squibb | 2021-04-15 |
| Sintilimab in Combination With Chidamide in Refractory and Relapsed AITL (NCT04831710) | Sun Yat-sen University | 2021-04-15 |
| Decitabine-primed Tandem CD19/CD20 CAR T Cells Treatment in r/r B-NHL (NCT04697940) | Han weidong | 2021-04-15 |
| Hyperbaric Versus Normobaric Oxygen Therapy for COVID-19 Patients (NCT04500626) | Ottawa Hospital Research Institute | 2021-04-15 |
| Oral Ibuprofen Versus Placebo in Treatment of Patent Ductus Arteriosus (PDA)in Preterm Infants (NCT05493540) | Nada Youssef | 2021-04-15 |
| Trial Evaluating the Efficacy of Systemic Mesenchymal Stromal Cell (MSC) Injections for the Treatment of Severe and Chronic Radiotherapy-induced Abdomino-pelvic Complications (Pelvic Radiation Disease, PRD) Refractory to Standard Therapy (NCT02814864) | Assistance Publique - Hôpitaux de Paris | 2021-04-14 |
| Trial of NanoPac Intratumoral Injection in Lung Cancer (NCT04314895) | NanOlogy, LLC | 2021-04-14 |
| An Evaluation of AXS-05 for the Treatment of TRD in Treatment-Adherent Patients (NCT04971291) | Axsome Therapeutics, Inc. | 2021-04-14 |
| Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder (NCT04620759) | Johns Hopkins University | 2021-04-14 |
| Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer (NCT04216316) | National Cancer Institute (NCI) | 2021-04-14 |
| Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies (NCT04902040) | M.D. Anderson Cancer Center | 2021-04-14 |
| Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab (NCT04270175) | Weill Medical College of Cornell University | 2021-04-14 |
| Total Lymphoid Irradiation Pre-HSCT in Severe Congenital Neutropenia (NCT04844177) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2021-04-14 |
| Preventive Dendritic Cell Vaccine, AV-COVID-19, in Subjects Not Actively Infected With COVID-19 (NCT05007496) | Aivita Biomedical, Inc. | 2021-04-14 |
| Neoadjuvant Therapy of GP Chemotherapy Combined With Tislelizumab in Locoregionally Advanced NPC (NCT04833257) | Sun Yat-sen University | 2021-04-14 |
| Efficacy of SJ733 in Adults With Uncomplicated Plasmodium Falciparum or Vivax Malaria (NCT04709692) | R. Kiplin Guy | 2021-04-14 |
| ANTIcoagulation in Severe COVID-19 Patients (NCT04808882) | Assistance Publique - Hôpitaux de Paris | 2021-04-14 |
| Advancing Postmenopausal Preventive Therapy (NCT04103476) | University of Southern California | 2021-04-13 |
| Human Umbilical Cord Mesenchymal Stem Cell(UC-MSC)Delayed Renal Chronic Kidney Disease(CKD3、4 ) (NCT05512988) | Tongji Hospital | 2021-04-13 |
| Testing SIROLIMUS in Beta-thalassemia Transfusion Dependent Patients (THALA-RAP) (NCT04247750) | Università degli Studi di Ferrara | 2021-04-13 |
| Efficacy and Safety of Rituximab in the First Episode of Pediatric Idiopathic Nephrotic Syndrome (NCT04783675) | Children's Hospital of Fudan University | 2021-04-13 |
| Durvalumab and Olaparib for the Treatment of Prostate Cancer in Men Predicted to Have a High Neoantigen Load (NCT04336943) | University of Washington | 2021-04-13 |
| Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis (NCT04878003) | Kartos Therapeutics, Inc. | 2021-04-13 |
| Non-Opioid Pain Medications After Intracapsular Adenotonsillectomy (NCT04791761) | David Chi, MD | 2021-04-13 |
| Deferoxamine for the Prevention of Cardiac Surgery-Associated Acute Kidney Injury (NCT04633889) | Brigham and Women's Hospital | 2021-04-13 |
| A Study Comparing Two Doses of AGTC-501 in Male Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (SKYLINE) (NCT06333249) | Beacon Therapeutics | 2021-04-13 |
| Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer (NCT03606967) | National Cancer Institute (NCI) | 2021-04-13 |
| Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults (NCT04782323) | Seqirus | 2021-04-13 |
| APG-2575 Monotherapy or in Combination With Lenalidomide/DXMS in Subjects With Relapsed or Refractory Multiple Myeloma (NCT04674514) | Ascentage Pharma Group Inc. | 2021-04-13 |
| GLUcose Transport and REnalPROtection in Chronic Kidney Disease (NCT05998837) | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | 2021-04-13 |
| HR021618 in Moderate to Severe Pain After Abdominal Surgery (NCT04811053) | Jiangsu HengRui Medicine Co., Ltd. | 2021-04-12 |
| Rigosertib for RDEB-SCC (NCT03786237) | Prof. Johann Bauer | 2021-04-12 |
| Methylene Blue-Enhanced Ultrafiltration Improves Outcomes After Cardiopulmonary Bypass (NCT07212842) | University of Sao Paulo | 2021-04-12 |
| Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors (NCT04802876) | SOLTI Breast Cancer Research Group | 2021-04-12 |
| A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Dosimetry, and Anti-tumor Activity of Ga-68-NGUL / Lu-177-DGUL in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Refractory to Standard Therapy (NCT05547061) | Cellbion Co., Ltd. | 2021-04-12 |
| Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis (NCT04607837) | Pfizer | 2021-04-12 |
| Study Assessing Efficacy and Safety of NFL-101 as a Tobacco Cessation Therapy (NCT04571216) | NFL Biosciences SAS | 2021-04-12 |
| Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection (NCT04920838) | ANRS, Emerging Infectious Diseases | 2021-04-12 |
| Safety and Efficacy Study of Human Umbilical Cord-Derived Mesenchymal Stem Cells(BC-U001) for Rheumatoid Arthritis (NCT04971980) | Beijing Baylx Biotech Co., Ltd. | 2021-04-12 |
| Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hepatitis B Virus (HBV) Infection (NCT04749368) | Brii Biosciences Limited | 2021-04-12 |
| Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma (NCT04469699) | University Hospital Muenster | 2021-04-12 |
| Investigating the Efficacy and Safety ICATIBANT For The Treatment of Patients With SARS-CoV-2 (COVID-19) Infection (NCT04978051) | Sebastian Videla | 2021-04-12 |
| Sodium Pyruvate Nasal Spray Treatment of COVID-19 Infection (NCT04824365) | Cellular Sciences, inc. | 2021-04-12 |
| Efficacy and Safety of Anlotinib, Irinotecan and Temozolomide in the Treatment of Refractory or Recurrent Neuroblastoma in Children: an Open, Single Arm, Single Center, Phase II Clinical Study (NCT04842526) | Tianjin Medical University Cancer Institute and Hospital | 2021-04-12 |
| COVID-19 and Anti-CD14 Treatment Trial (NCT04391309) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-04-12 |
| Clinical Study in the Treatment of Patients With Moderate Course of COVID-19 (NCT04842435) | Microgen | 2021-04-12 |
| LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC (NCT04759664) | Lutris Pharma Ltd. | 2021-04-12 |
| Clinical Trial to Evaluate the Safety and Efficacy of ATR-002 in Adult Hospitalized Patients With COVID-19 (NCT04776044) | Atriva Therapeutics GmbH | 2021-04-12 |
| A Clinical Trial to Evaluate PCS499 in Treating Ulcerations in Patients Who Have Necrobiosis Lipoidica (NCT04800562) | Processa Pharmaceuticals | 2021-04-12 |
| Phase II Study of Concurrent Lenvatinib and Radiotherapy for Advanced HCC (NCT04791176) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2021-04-12 |
| Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer (NCT04519151) | Sheba Medical Center | 2021-04-12 |
| Brazilian Green Propolis Extract (EPP-AF) as an Adjunct Treatment for Hospitalized COVID-19 Patients (BeeCovid2) (NCT04800224) | D'Or Institute for Research and Education | 2021-04-12 |
| Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors (NCT04717375) | Sanofi | 2021-04-11 |
| OSE2101+FOLFIRI, or FOLFIRI Maintenance After FOLFIRINOX-based Induction Therapy in Advanced or Metastatic PDAC (NCT03806309) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2021-04-10 |